Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
Roche and Sarepta Therapeutics enters licensing agreement in order to improve the lives of patients living with Duchenne muscular dystrophy
admin
-
December 24, 2019
0
Latest Pharma-News
FibroGen Submits New Drug Application to the U.S. FDA for Roxadustat for the treatment of anemia of chronic kidney disease (CKD)
admin
-
December 24, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration(FDA) approved Intra-Cellular Therapie’s Novel Antipsychotic CAPLYTA® (lumateperone) for the treatment of schizophrenia in adults
admin
-
December 24, 2019
0
Latest Pharma-News
Zosano Announces FDA Submission of 505(b)(2) New Drug Application for Qtrypta for the acute treatment of migraine
admin
-
December 24, 2019
0
Latest Pharma-News
U.S FDA issues complete response letter to ViiV Healthcare for the use of investigational cabotegravir and rilpivirine long-acting regimen for the treatment of HIV
admin
-
December 23, 2019
0
Latest Pharma-News
U.S. FDA approved priority review to sNDA for Braftovi® (encorafenib) in combination with erbitux® (cetuximab) (braftovi doublet) for the treatment of Brafv600e-mutant metastatic colorectal...
admin
-
December 20, 2019
0
Latest Pharma-News
Galapagos in collaboration with Gilead submits NDA to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment
admin
-
December 20, 2019
0
Latest Pharma-News
Oxidien Pharmaceuticals Announces encouraging Response from FDA on Proposed Development Plan
admin
-
December 20, 2019
0
Latest Pharma-News
Bristol-Myers Squibb Announces Submission of Biologics License Application to the U.S. Food and Drug Administration (FDA) for CAR T-Cell Therapy Lisocabtagene Maraleucel (liso-cel)
admin
-
December 19, 2019
0
Latest Pharma-News
FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™ (enfortumab vedotin-ejfv) for the treatment of locally Advanced or Metastatic Urothelial Cancer
admin
-
December 19, 2019
0
Latest Pharma-News
Novartis provides update on (fevipiprant) LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
admin
-
December 19, 2019
0
Latest Pharma-News
Roche concludes getting hold of Spark Therapeutics, Inc. to reinforce presence in gene therapy
admin
-
December 18, 2019
0
1
...
135
136
137
...
145
Page 136 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025